Potential Accounting Implications of Supreme Court Decision on the Affordable Care Act

  • Print-friendly version
05/31/2012 by Pharmaceuticals & life science
Potential Accounting Implications of Supreme Court Decision on the Affordable Care Act

At a glance

The Supreme Court heard arguments concerning the Affordable Care Act in March 2012 and expects to issue its decision on the constitutionality of the Affordable Care Act by the end of June 2012. If the law should be invalidated by the Supreme Court, either in whole or in part, there could be significant accounting and financial reporting implications. This PwC Pharmaceutical and Life Sciences Industry Alert focuses on the potential accounting implications of the Supreme Court decision on the Affordable Care Act.

The Supreme Court heard arguments concerning the Affordable Care Act in March 2012 and expects to issue its decision on the constitutionality of the Affordable Care Act by the end of June 2012. If the law should be invalidated by the Supreme Court, either in whole or in part, there could be significant accounting and financial reporting implications. Pharmaceutical and life sciences companies may wish to consider these potential implications in advance of the Court's ruling, as the time to address such changes in the June 30, 2012 reporting period may be short.

This PwC Pharmaceutical and Life Sciences Industry Alert focuses on the potential accounting implications of the Supreme Court decision on the Affordable Care Act.